Articles and posts USelectAllNewsPresentationsArticlesInterview with CEO Hanna Sjöström about the clinical study and the rights issueSeptember 22, 2022 | News, PresentationsClinical study on 100 newborn babies with Neola Medical’s medical technology device completed, positive subgroup results presentedSeptember 21, 2022 | News, Non regulatoryPresentation at ABG Sundal Collier’s Investor Day 2022September 20, 2022 | News, PresentationsAcquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letterSeptember 15, 2022 | News, Non regulatoryNeola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of SeptemberSeptember 12, 2022 | News, Non regulatoryNeola Medical AB: Notice of extraordinary general meeting in Neola Medical ABSeptember 8, 2022 | News, Non regulatoryThe board of directors of Neola Medical has resolved on a rights issue of approximately SEK 55 million subject to approval by an Extraordinary General MeetingSeptember 8, 2022 | News, RegulatoryNeola Medical at the UENPS congress 2022September 6, 2022 | NewsDo not miss BioStock’s latest article about Neola Medical with CEO Hanna SjöströmSeptember 1, 2022 | NewsClinical Manager recruited – Neola Medical strengthens the team with a neonatologistSeptember 1, 2022 | News, Non regulatoryCEO Hanna Sjöström at The Future of Swedish & Danish Life Science 7th of SeptemberAugust 25, 2022 | NewsCEO and CFO presents Q2 report for 2022August 17, 2022 | News, Presentations# 12345678910111213141516171819202122232425262728 $ For InvestorsWe are on a journey to revolutionize neonatal intensive careLearn more about investing in Neola Medical Join our journey
Interview with CEO Hanna Sjöström about the clinical study and the rights issueSeptember 22, 2022 | News, Presentations
Clinical study on 100 newborn babies with Neola Medical’s medical technology device completed, positive subgroup results presentedSeptember 21, 2022 | News, Non regulatory
Acquisition of IP rights, clinical study results, owner’s increased shares and the coming rights issue – CEO tells more in Neola Medicals investor letterSeptember 15, 2022 | News, Non regulatory
Neola Medical’s CEO Hanna Sjöström presents at ABG Sundal Colliers Investor Day the 13th of SeptemberSeptember 12, 2022 | News, Non regulatory
Neola Medical AB: Notice of extraordinary general meeting in Neola Medical ABSeptember 8, 2022 | News, Non regulatory
The board of directors of Neola Medical has resolved on a rights issue of approximately SEK 55 million subject to approval by an Extraordinary General MeetingSeptember 8, 2022 | News, Regulatory
Do not miss BioStock’s latest article about Neola Medical with CEO Hanna SjöströmSeptember 1, 2022 | News
Clinical Manager recruited – Neola Medical strengthens the team with a neonatologistSeptember 1, 2022 | News, Non regulatory
CEO Hanna Sjöström at The Future of Swedish & Danish Life Science 7th of SeptemberAugust 25, 2022 | News